PEPTIDE POSSESSING MESENCHYMAL-STEM-CELL MOBILIZING ACTIVITY

The present inventors designed an artificial sequence peptide based on the results of original research conducted so far, and found that the peptide exhibits an activity of mobilizing mesenchymal stem cells into peripheral blood. The present inventors also found that the artificial sequence peptide...

Full description

Saved in:
Bibliographic Details
Main Authors TAMAI, Katsuto, YAMAZAKI, Takehiko, YOKOTA, Koichi, SHIMBO, Takashi
Format Patent
LanguageEnglish
French
German
Published 03.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present inventors designed an artificial sequence peptide based on the results of original research conducted so far, and found that the peptide exhibits an activity of mobilizing mesenchymal stem cells into peripheral blood. The present inventors also found that the artificial sequence peptide has a therapeutic effect on inflammatory bowel disease, atopic dermatitis, and cerebral infarction. Based on these findings, a new regenerative medicine technology that can overcome the problems of cell transplantation therapy is provided.
Bibliography:Application Number: EP20190869158